DDC

DDC Overview

English NameAromatic-L-amino-acid decarboxylaseApproved Drugs8
Drugs in Clinical Trials13Target SynonymEC:4.1.1.28,EC 4.1.1,DDC,AADC,Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase),Aromatic-L-Amino-Acid Decarboxylase,Aromatic L-Amino Acid Decarboxylase,EC 4.1.1.28,DOPA decarboxylase
Highest Development StageApproved
English NameAromatic-L-amino-acid decarboxylase
Target SynonymEC:4.1.1.28,EC 4.1.1,DDC,AADC,Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase),Aromatic-L-Amino-Acid Decarboxylase,Aromatic L-Amino Acid Decarboxylase,EC 4.1.1.28,DOPA decarboxylase
Approved Drugs8
Drugs in Clinical Trials13
Highest Development StageApproved

DDC Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Total: 1
  • 1

DDC Background

Dopa decarboxilase (DDC), also known as aromatic amino acid decarboxylase, is a group II decarboxylase. The enzyme catalyzes the decarboxylation of aromatic L-amino acids to produce the corresponding amines. DDC produces the neurotransmitters dopamine and serotonin from L-Dopa and L-5-hydroxytryptophan, respectively. DDC inhibitors is in clinical use to treat Parkinson's disease(PD), usually co-administrated with L-DOPA. DDC would block peripheral conversion to dopamine and allow a greater percentage of L-DOPA to reach the brain, causing an increase in brain dopamine levels, and reducing the side effects of dopamine-rich blood.

DDC Synonyms

Aromatic-L-amino-acid decarboxylase,Dopa decarboxilase,AADC
  • Overview
  • Product List